Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage

OBJECTIVES: (1) To assess innate ex vivo production of interleukin 1β (IL1β) and interleukin 1 receptor antagonist (IL1Ra) in patients with recent‐onset rheumatoid arthritis (RA) as compared with healthy controls; (2) to assess the association of ex vivo IL1β and IL1Ra production with progression of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: de Vries‐Bouwstra, J K, Goekoop‐Ruiterman, Y P M, Wesoly, J, Hulsmans, H J, de Craen, A J M, Breedveld, F C, Dijkmans, B A C, Allaart, C F, Huizinga, T W J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2007
Aiheet:
Extended Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1954691/
https://ncbi.nlm.nih.gov/pubmed/17223662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.062463
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia